Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Interactive Kiosk at The Heart Institute Illustrates Alternative Treatments for Atrial Fibrillation
  • USA - English


News provided by

The Heart Institute

Aug 08, 2013, 10:20 ET

Share this article

Share toX

Share this article

Share toX

Medical Director, Joseph T. McGinn and Director of Electrophysiology, Soad Bekheit introduce their new kiosk that features information on cryoablation, a minimally invasive treatment offered at THI.
Medical Director, Joseph T. McGinn and Director of Electrophysiology, Soad Bekheit introduce their new kiosk that features information on cryoablation, a minimally invasive treatment offered at THI.

Staten Island, NY (PRWEB) August 08, 2013 -- The Heart Institute's Medical Director and Cardiac Surgeon, Joseph T. McGinn along with the Director of Electrophysiology, Soad Bekheit, unveiled their first interactive kiosk displaying educational content on atrial fibrillation (A-fib). The kiosk is displayed in their Anticoagulation Service Coumadin Center and features videos about the advanced A-Fib solution,Cryoballoon Ablation (Cryoablation).

Cryoablation is one of the many innovative and minimally invasive treatments for A-Fib offered at The Heart Institute.

Post this

A-Fib is the most common and undertreated form of arrhythmia that currently affects about 2 million Americans each year. This type of arrhythmia is due to delayed electrical signals that cause the heart to contract at an abnormal rate. In most cases, patients are treated with pharmaceutical options, which include blood thinners, such as Coumadin (warfarin), rate control drugs and anti-arrhythmic drugs. However, many of these medications require a daily intake and have strong side effects such as abnormal profuse bleeding internally or externally along with other adverse health reactions.

Cryoablation is one of the many innovative and minimally invasive treatments for A-Fib offered at The Heart Institute. Electrophysiologist, Dr. Marcin Kowalski, who performs this procedure at the Heart Institute, was the first doctor in the tri-state area to perform the cryoablation right after FDA approval. When conducting this procedure, a freezing air that reaches -70°C is released in the pulmonary vein to target the abnormal electrical signals that encourage heartbeat irregularities. A balloon-like tool used in this procedure allows the vein to be closed off from any new erratic signals while also releasing a large amount of freezing air that ablates current irregular signals to the heart.

Restoring a healthy heart rhythm through the use of cold air is known to be less disruptive to the cardiac tissue and the surrounding internal body elements. The medical devices used in this procedure were approved by the FDA after a study demonstrated that 70 percent of patients treated with cryoablation were free from A-Fib at one year, compared to 7 percent of patients who proceeded with a pharmaceutical treatment.

The Heart Institute also offers other treatments to A-Fib such as Cardioversion, Maze Procedures, PVAI (Pulmonary Vein Antrum Isolation), and AV Node Ablation. For more information, The Heart Institute, Dr.Marcin Kowaslki, Cryoablation or other A-Fib treatments please contact Richard A. Clarke at 917-868-1407 or RClarke(at)TheHeartInstituteNY(dot)com.

------

About The Heart Institute

The Heart Institute opened in 2001 and operates at the North Campus of Staten Island University Hospital at 475 Seaview Avenue. It is one of the nation’s leading heart hospitals known for its pioneering techniques in heart surgery, angioplasties and electrophysiology (A-fib) in addition to its most advanced diagnostic technologies, post-surgical outpatient care and cardiac prevention programs. Procedures include coronary bypass operations, heart valve repair/replacements, angioplasties, cardiac ablations and cardiac catheterizations. Staten Island University Hospital is a member of the North Shore – LIJ Health System.

Richard A. Clarke, The Heart Institute, http://www.theheartinstituteny.com, 212.545.7435, [email protected]

Modal title

Dr. Marcin Kowalksi was the first electrophysiologist to perform cryoablation in the tri-state area after the FDA approval.
Dr. Marcin Kowalksi was the first electrophysiologist to perform cryoablation in the tri-state area after the FDA approval.
The Heart Institute at Staten Island University Hospital
The Heart Institute at Staten Island University Hospital
Dr. Marcin Kowalksi was the first electrophysiologist to perform cryoablation in the tri-state area after the FDA approval. The Heart Institute at Staten Island University Hospital

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.